Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Alzheimer's Disease in Women: Risks and Benefits of Hormone Therapy -Continuation of: "The Kronos Early Estrogen Prevention Study (KEEPS)"

NCT03718494 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03718494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03718494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Alzheimer's Disease in Women: Risks and Benefits of Hormone Therapy -Continuation of: "The Kronos Early Estrogen Prevention Study (KEEPS)"
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
May 22, 2019
Completion date
September 1, 2022
Enrollment
299 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia